Economic value of influenza vaccination

Chiara Cadeddu, Maria Lucia Specchia, Gualtiero Ricciardi, Chiara De Waure, Maria Assunta Veneziano, Silvio Capizzi, Stefano Capri

Risultato della ricerca: Contributo in rivistaArticolo in rivista

17 Citazioni (Scopus)

Abstract

Influenza epidemics are responsible for high mortality and morbidity rates in particular among elderly and high risk groups. This review is aimed at assessing the economic value of vaccination in these groups. A search of full economic evaluations of influenza vaccination in comparison with no interventions was performed on PubMed from January 1990 to May 2011. Only economic evaluations dealing with elderly and high risk groups were considered. The quality of selected articles was assessed through Drummond's checklist. Sixteen cost-effectiveness analyses and four cost-benefit analyses were included: overall, the quality of studies was fairly good. The vaccination was demonstrated to be cost-effective or cost-saving in almost all studies, independently by the perspective and the type of analysis. Influenza vaccination is a worthwhile intervention from the pharmacoeconomic view-point, anyway a standardization of methods should be desirable in order to guarantee the comparability and transferability of results.
Lingua originaleEnglish
pagine (da-a)119-129
Numero di pagine11
RivistaHUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume8
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Economic evaluation
  • Influenza
  • Vaccine

Fingerprint

Entra nei temi di ricerca di 'Economic value of influenza vaccination'. Insieme formano una fingerprint unica.

Cita questo